---
aliases: /news/fda-grants-accelerated-approval-for-alzheimers-drug
archetype: curated-content
author:
  - Radhika Narayanan
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - FDA Grants Accelerated Approval for Alzheimer’s Drug
categories:
  - 'Medigy: Neurology'
categorySlug:
  - 'medigy: neurology'
categoryUrl:
  - topic/medigy-neurology
categoryLabel:
  - Neurology
contentCategories: netspective-medigy-news-curated-content
institution: null
offering: null
layOut: single
date: '2021-06-09'
description: >-
  The FDA approved a drug for the treatment of Alzheimer’s DiseaseToday, the
  U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the
  treatment of Alzheimer’s, a debilitating disease affe
favIconImage: null
featuredImage:
  alt: FDA Grants Accelerated Approval for Alzheimer’s Drug
  format: JPEG
  href: f954897a-0dbf-54b7-9a51-33e4114bcf40-featuredImage.jpeg
  size:
    - 675
    - 1200
  valid: true
  workPackage: 6350
  wpAttachment:
    fileName: Curated_Featured_Image.png
    link: /api/v3/attachments/14034/content
featuredPdf: null
htmlMetaData:
  author: null
  description: >-
    The FDA approved a drug for the treatment of Alzheimer’s under the
    accelerated approval pathway, which can be used for a drug for a serious or
    life-threatening illness that provides meaningful therapeutic advantage over
    existing treatments.
  generator: null
  viewport: 'width=device-width, initial-scale=1.0'
  articlemodified_time: 'Mon, 06/07/2021 - 11:20'
  articlepublished_time: 'Mon, 06/07/2021 - 11:25'
  msvalidate.01: null
  ogdescription: The FDA approved a drug for the treatment of Alzheimer’s Disease
  ogimage: 'https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png'
  ogsite_name: U.S. Food and Drug Administration
  ogtitle: FDA Grants Accelerated Approval for Alzheimer’s Drug
  ogtype: Article
  ogupdated_time: 'Mon, 06/07/2021 - 11:20'
  ogurl: >-
    https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug
  yandex-verification: null
  robots: null
  fbapp_id: null
  oglocale: null
  fbadmins: null
  articlepublisher: FDA
  google-site-verification: tWxlDhm4ANdksJZPj7TBmHgNoMqZCnecPp0Aa2vC9XA
  keywords: null
id: 6350
identifier: News
lastMod: '2021-06-09T09:42:43.940051Z'
link:
  brand: fda.gov
  href: >-
    https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug
  original: >-
    https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug
href: >-
  https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug
original: >-
  https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug
mastHead: NEWS
mdName: f954897a-0dbf-54b7-9a51-33e4114bcf40.md
openGraphMetaData:
  ogdescription: The FDA approved a drug for the treatment of Alzheimer’s Disease
  ogtitle: FDA Grants Accelerated Approval for Alzheimer’s Drug
  ogurl: >-
    https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug
  ogimage: 'https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png'
  ogsite_name: U.S. Food and Drug Administration
  ogtype: Article
  ogupdated_time: 'Mon, 06/07/2021 - 11:20'
  ogimageheight: null
openProjectCustomFields:
  cleanUrl: >-
    https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug
  medigyTopics:
    - 'Medigy: Neurology'
  sourceUrl: >-
    https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug
openProjectWorkPackageType: Curated Content
searchCategory: News
slug: fda-fda-grants-accelerated-approval-for-alzheimers-drug
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: FDA Grants Accelerated Approval for Alzheimer’s Drug
via: ' '
insights_description: null
insights_name: null
viaLink: null
relatedOfferings: null
twitterMetaData:
  twittercard: summary_large_image
  twitterdescription: The FDA approved a drug for the treatment of Alzheimer’s Disease
  twittertitle: FDA Grants Accelerated Approval for Alzheimer’s Drug
  twitterimage: 'https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png'
  twitterurl: null
---
<p>The FDA approved a drug for the treatment of Alzheimer’s Disease<br><br>Today, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the <a href="https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/accelerated-approval">accelerated approval pathway</a>, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments. Accelerated approval can be based on the drug’s effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit to patients, with a required post-approval trial to verify that the drug provides the expected clinical benefit.&nbsp;</p>